2021 to 2022 Saw 3 Percent Increase in Infant Deaths Reported in U.S.
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 25, 2024 -- There was a 3 percent increase in infant deaths reported in the United States from 2021 to 2022, according to the July 24 National Vital Statistics Reports, a publication from the National Center for Health Statistics.
Danielle M. Ely, Ph.D., and Anne K. Driscoll, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, present final 2022 infant mortality statistics using data for all 50 states and the District of Columbia. The authors also examined trends in infant mortality.
The researchers found that there were 20,577 infant deaths reported in the United States in 2022, which represented a 3 percent increase from 2021. From 2021 to 2022, the U.S. infant mortality rate increased 3 percent, from 5.44 to 5.61 infant deaths per 1,000 live births. During the same time period, the neonatal mortality rate increased 3 percent, from 3.49 to 3.59, and the postneonatal mortality rate increased 4 percent, from 1.95 to 2.02. Compared with 2021, in 2022, the overall infant mortality rate increased for infants of American Indian and Alaska Native non-Hispanic, White non-Hispanic, and Dominican women; changes in rates for other race and Hispanic origin groups were not significant.
From 2021 to 2022, mortality rates increased among preterm infants (33.59 to 34.78) and for infants born term (2.08 to 2.18). In 2022, the five leading causes of infant death were the same as in 2021.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-26 05:15
Read more
- Study Assesses Risk for 28-Day Hospitalization for Adults With RSV
- AI Helps Spot Brain Tumor Tissue Surgeons Miss
- COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease
- Brief Cognitive Behavioral Therapy Via Telehealth Cuts Suicide Attempts
- New Hope Against a Rare, Aggressive Form of Thyroid Cancer
- Florida Fails to Pass Amendment Legalizing Recreational Weed
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions